» Authors » Hideo Shojaku

Hideo Shojaku

Explore the profile of Hideo Shojaku including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 61
Citations 293
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tram Anh D, Takakura H, Nakazato A, Morita Y, Shojaku H
Acta Otolaryngol . 2023 Nov; 143(10):840-844. PMID: 37995205
Background: Long-term efficacy of middle ear pressure therapy (MEPT) with the EFET01 device in patients in Japan with definitive Ménière's disease (MD) and delayed endolymphatic hydrops (DEH) was evaluated. Objective:...
2.
Iwasaki S, Kawahara T, Miyashita T, Shindo S, Tsubota M, Inoue A, et al.
Auris Nasus Larynx . 2023 Oct; 51(2):343-346. PMID: 37838569
Objective: To assess the annual incidence of vestibular neuritis (VN) in the Japanese population. Methods: We conducted a mail-based survey targeting otolaryngologic clinics and hospitals across Japan to estimate the...
3.
Takeda N, Sato G, Matsuda K, Ito J, Omori K, Ito Y, et al.
Auris Nasus Larynx . 2023 Sep; 51(2):401-405. PMID: 37666746
Objective: In the present study, we examined the effects of high-dose betahistine on dizziness handicap inventory (DHI) scores in patients with unilateral vestibulopathy. Methods: An uncontrolled, open-label, multicenter clinical trial...
4.
Tram Anh D, Takakura H, Nakazato A, Shojaku H
Acta Otolaryngol . 2023 Aug; 143(8):655-661. PMID: 37537955
Background: As a low-cost, portable, handheld air pressure generation tool not requiring a ventilation tube, the EFET01 device has shown clinical effectiveness for intractable Ménière's disease (MD) patients in Japan....
5.
Hashimoto M, Koizuka I, Yamashita H, Suzuki M, Omori K, Origasa H, et al.
Auris Nasus Larynx . 2022 Dec; 51(1):31-37. PMID: 36581537
Objective: To provide diagnostic and therapeutic strategies for vestibular neuritis in accordance with the Japanese Clinical Practice Guidelines for Vestibular Neuritis 2021. Methods: The Committee for Clinical Practice Guidelines for...
6.
Ito S, Takakura H, Akaogi K, Shojaku H, Kitahara T, Nishio S, et al.
Acta Otolaryngol . 2022 Dec; 142(9-12):675-678. PMID: 36519274
Background: Delayed endolymphatic hydrops (DEH) is a rare disease, and the actual number of patients in Japan remains unknown. Objective: To investigate the number and prevalence of patients with DEH...
7.
Tram Anh D, Takakura H, Asai M, Ueda N, Shojaku H
Sci Rep . 2022 Dec; 12(1):20805. PMID: 36460741
Machine learning is considered a potential aid to support human decision making in disease prediction. In this study, we determined the utility of various machine learning algorithms in classifying peripheral...
8.
Nakazato A, Mochizuki M, Shibuya-Takahashi R, Fujimori H, Fujii K, Saijoh S, et al.
Sci Rep . 2022 Oct; 12(1):17751. PMID: 36273237
CD271 (also referred to as nerve growth factor receptor or p75) is expressed on cancer stem cells in hypopharyngeal cancer (HPC) and regulates cell proliferation. Because elevated expression of CD271...
9.
Ito S, Takakura H, Akaogi K, Shojaku H, Takeda N, Suzuki M, et al.
Acta Otolaryngol . 2022 Aug; 142(7-8):568-574. PMID: 35984435
Background: Delayed endolymphatic hydrops (DEH) is an inner ear disease that causes recurrent vertigo in the ipsilateral ear or fluctuating hearing in the contralateral ear due to endolymphatic hydrops secondary...
10.
Nakazato A, Takakura H, Ueda N, Do T, Takeda N, Watanabe Y, et al.
Acta Otolaryngol . 2022 Jun; 142(6):491-498. PMID: 35723676
Background: Middle ear pressure therapy (MEPT) is effective for intractable vertigo in patients with definite Meniere's disease (MD) and treatment-refractory delayed endolymphatic hydrops (DEH). Four-month MEPT with the EFET01, an...